Kane Biotech Inc. (Kane) is a Canada-based company engaged in the development and commercialization of products that prevent and remove microbial biofilms. The Company’s technologies include DispersinB, Aledex, StrixNB and KBI Antibacterial Disinfectant (KBI). Kane’s technology for the wound care market is DispersinB. The Company has a number of DispersinB formulations in development, including formulations with antibiotics and the antibiofilm enzyme B-N-Acetylglucosaminidase. Kane has developed antibiofilm-antimicrobial formulations for both the veterinary and human markets. The Aledex is used in medical device coating market. The KBI contains antimicrobial-antibiofilm combination consists of Chlorhexidine (CHX) and Sodium Metaperiodate (SMP). The StrixNB is used for the oral care market.